Listen "Operational Pathways for Biomarker Testing in NSCLC"
Episode Synopsis
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test results, clinical application of ctDNA testing as well as strategies for documentation of results for ease of retrieval. Sponsored by AmgenIf you have any questions for today’s guests, or have a topic you would like to hear more about, email [email protected].
More episodes of the podcast OnCall
Inflation Reduction Act: Current State
14/08/2025
Q2 GPO Legislative Townhall
31/07/2025
Inflation Reduction Act: Overview
22/07/2025
505(b)(2) Billing and Reimbursement
17/04/2025
505(b)(2) Landscape and Pipeline
03/04/2025
505(b)(2) Basics
18/03/2025
Buy and Bill: Practice Perspective
04/02/2025
Buy and Bill: The Basics
22/01/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.